Glutaminase inhibition as potential cancer therapeutics: current status and future applications
AbstractAlterations in normal metabolic processes are defining features of cancer. Glutamine, an abundant amino acid in the human blood, plays a critical role in regulating several biosynthetic and bioenergetic pathways that support tumour growth. Glutaminolysis is a metabolic pathway that converts...
Saved in:
Main Authors: | Rajath Cyriac (Author), Kwangho Lee (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Augmented Therapeutic Potential of Glutaminase Inhibitor CB839 in Glioblastoma Stem Cells Using Gold Nanoparticle Delivery
by: Beatriz Giesen, et al.
Published: (2021) -
GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells
by: Juan De los Santos-Jiménez, et al.
Published: (2024) -
The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
by: Bryan J. Neth, et al.
Published: (2023) -
Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors
by: Gatot Nyarumenteng Adhipurnawan Winarno, et al.
Published: (2023) -
Chapter The Rise of Glutaminase in End-Stage Liver Diseases
by: Jalan, Rajiv
Published: (2012)